DMK Pharmaceuticals Corporation
DMKPQ
$0.00
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 940.75% | -79.34% | 186.65% | -55.31% | -72.74% |
| Total Receivables | -- | -10.38% | -98.05% | -30.18% | 62.54% |
| Inventory | -0.21% | 0.00% | -46.37% | 13.40% | 148.16% |
| Prepaid Expenses | -22.50% | -18.08% | -24.82% | 23.24% | 0.96% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -95.22% | -49.71% | -38.13% | 15.61% | -0.81% |
| Total Current Assets | 128.13% | -54.28% | -18.61% | -8.09% | -34.15% |
|
|
|||||
| Total Current Assets | 128.13% | -54.28% | -18.61% | -8.09% | -34.15% |
| Net Property, Plant & Equipment | -16.53% | -12.74% | -8.07% | -19.55% | -13.98% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | -81.42% | 0.00% | 0.00% | 0.00% |
| Total Assets | 88.61% | -47.67% | -16.97% | -9.94% | -31.41% |
|
|
|||||
| Total Accounts Payable | -12.25% | 16.20% | 23.23% | 49.83% | 17.29% |
| Total Accrued Expenses | 5.59% | 20.28% | 21.16% | 12.54% | -49.84% |
| Short-term Debt | -- | 34.56% | -57.42% | -25.07% | -32.15% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -59.80% | -37.22% | -26.91% | -7.10% | 1.77% |
| Total Finance Division Other Current Liabilities | -0.54% | 15.73% | -26.35% | -10.82% | -7.06% |
| Total Other Current Liabilities | -0.54% | 15.73% | -26.35% | -10.82% | -7.06% |
| Total Current Liabilities | -10.29% | 15.90% | 13.62% | 28.42% | -8.74% |
|
|
|||||
| Total Current Liabilities | -10.29% | 15.90% | 13.62% | 28.42% | -8.74% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | 34.56% | -57.42% | -25.07% | -32.15% |
| Capital Leases | -- | -- | -- | -- | -59.80% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -62.85% | -78.11% | 2,943.56% | -5.83% | -74.41% |
| Total Liabilities | -14.30% | -12.67% | 60.60% | 26.79% | -14.25% |
|
|
|||||
| Common Stock & APIC | 2.55% | 2.12% | 0.02% | -0.11% | 0.07% |
| Retained Earnings | -0.43% | -2.73% | -2.94% | -1.10% | -1.48% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | 55.23% | -22.14% | -1,098.08% | -128.40% | -59.59% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 109.79% | 0.00% | 0.00% | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 109.79% | 0.00% | 0.00% | -- |
|
|
|||||
| Total Common Equity | 55.23% | -22.14% | -1,098.08% | -128.40% | -59.59% |
| Total Preferred Equity | 0.00% | 109.79% | 0.00% | 0.00% | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 56.81% | -20.69% | -1,363.49% | -121.67% | -57.36% |
|
|
|||||